Optimize.health recently raised $15.6 million in Series A funding as it works to develop remote patient monitoring software. It’s just one more example of how the pandemic has prodded healthcare technology research and development.
The Seattle-based startup first gained attention for Pillsy, a smart bottle that reminds people when to take their meds via Bluetooth. Now the company is focused on measuring the impact of medication adherence by pulling data from devices that measure indicators such as blood pressure and combining it with medication adherence to send to a doctor.
The technology grew out of federal expansion of insurance coverage of remote patient monitoring services made last year by the Centers for Medicare and Medicaid Service.
The recent funding round was led by U.S. Venture Partners and others named in a LinkedIn post last week by CEO Jeff LeBrun.
“There’s more demand for remote care than ever before,” LeBrun told MedCityNews. “With Covid, it became less of a nice-to-have and more of an existential moment.”